47 U.S. lawmakers have disclosed 119 AbbVie Inc. trades under the STOCK Act — 68 buys and 51 sells between 2014 and 2026. Congress has been net buyers of ABBV, and their disclosed buys are up 35.7% versus the latest close.
*Notional-weighted price return on lawmakers' disclosed buys of ABBV, marked to the latest close — per-share (share counts aren't disclosed).
Lawmakers ranked by notional-weighted return on their disclosed ABBV buys (last ~3y), marked to the latest close.
| Date | Member | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2026-05-05 | Josh Gottheimer | SELL | $1K–$15K | $206.11 | $250.82 2026-08-13 | +49.4% rt |
| 2026-03-27 | Alan Armstrong | BUY | $15K–$50K | $209.40 | $250.82 2026-08-13 | +19.8% |
| 2025-08-22 | John Boozman | SELL | $1K–$15K | $210.60 | $250.82 2026-08-13 | -19.1% exit |
| 2025-08-11 | John Boozman | SELL | $1K–$15K | $198.64 | $250.82 2026-08-13 | -26.3% exit |
| 2025-08-04 | Marjorie Taylor Greene | BUY | $1K–$15K | $197.19 | $250.82 2026-08-13 | +27.2% |
| 2025-07-11 | Ritchie John Torres | SELL | $1K–$15K | $192.45 | $250.82 2026-08-13 | +0.3% rt |
| 2025-05-22 | Josh Gottheimer | BUY | $1K–$15K | $182.54 | $250.82 2026-08-13 | +37.4% |
| 2025-04-07 | Jared Moskowitz | BUY | $1K–$15K | $186.55 | $250.82 2026-08-13 | +34.5% |
| 2025-04-03 | Dwight Evans | SELL | $1K–$15K | $201.64 | $250.82 2026-08-13 | +46.1% rt |
| 2025-03-17 | Marjorie Taylor Greene | BUY | $1K–$15K | $214.47 | $250.82 2026-08-13 | +16.9% |
| 2025-02-05 | Rohit Khanna | SELL | $1K–$15K | $191.75 | $250.82 2026-08-13 | -30.8% exit |
| 2025-02-04 | Rohit Khanna | SELL | $1K–$15K | $189.95 | $250.82 2026-08-13 | -32.0% exit |
| 2025-01-15 | Jared Moskowitz | BUY | $1K–$15K | $171.35 | $250.82 2026-08-13 | +46.4% |
| 2024-12-16 | Rohit Khanna | SELL | $1K–$15K | $171.63 | $250.82 2026-08-13 | -46.1% exit |
| 2024-12-06 | Virginia Foxx | BUY | $1K–$15K | $176.19 | $250.82 2026-08-13 | +42.4% |
| 2024-11-20 | Marjorie Taylor Mrs Greene | BUY | $1K–$15K | $167.76 | $250.82 2026-08-13 | +49.5% |
| 2024-09-26 | Ritchie John Torres | BUY | $1K–$15K | $191.90 | $250.82 2026-08-13 | +30.7% |
| 2024-04-10 | Michael C. Burgess | SELL | $1K–$15K | $169.03 | $250.82 2026-08-13 | -48.4% exit |
| 2024-04-03 | Thomas H Tuberville | BUY | $1K–$15K | $177.33 | $250.82 2026-08-13 | +41.4% |
| 2024-01-19 | Thomas H Tuberville | SELL | $1K–$15K | $164.77 | $250.82 2026-08-13 | -52.2% exit |
| 2023-12-08 | Michael C. Burgess | SELL | $1K–$15K | $149.28 | $250.82 2026-08-13 | -68.0% exit |
| 2023-11-20 | Thomas H Tuberville | SELL | $1K–$15K | $138.31 | $250.82 2026-08-13 | -7.3% rt |
| 2023-10-24 | Greg Stanton | SELL | $1K–$15K | $146.31 | $250.82 2026-08-13 | -4.9% rt |
| 2023-10-17 | Thomas H Tuberville | BUY | $1K–$15K | $149.18 | $250.82 2026-08-13 | +68.1% |
| 2023-09-28 | Robert J. Wittman | SELL | $1K–$15K | $152.25 | $250.82 2026-08-13 | +78.2% rt |
| 2023-09-26 | Greg Stanton | BUY | $1K–$15K | $153.91 | $250.82 2026-08-13 | +63.0% |
| 2023-08-14 | Michael C. Burgess | SELL | $15K–$50K | $152.27 | $250.82 2026-08-13 | +10.9% rt |
| 2023-07-06 | Michael C. Burgess | BUY | $15K–$50K | $137.25 | $250.82 2026-08-13 | +82.8% |
| 2023-04-03 | Thomas H Tuberville | SELL | $1K–$15K | $160.42 | $250.82 2026-08-13 | -56.4% exit |
| 2023-04-03 | Thomas H Tuberville | SELL | $1K–$15K | $160.42 | $250.82 2026-08-13 | -2.0% rt |
| 2022-09-12 | Kathy Manning | BUY | $1K–$15K | $142.24 | $250.82 2026-08-13 | +76.3% |
| 2022-08-05 | Dwight Evans | BUY | $1K–$15K | $138.04 | $250.82 2026-08-13 | +81.7% |
| 2022-06-16 | Robert J. Wittman | BUY | $1K–$15K | $139.15 | $250.82 2026-08-13 | +80.3% |
| 2022-03-30 | Thomas H Tuberville | BUY | $1K–$15K | $163.75 | $250.82 2026-08-13 | +53.2% |
| 2022-02-18 | Josh Gottheimer | BUY | $1K–$15K | $144.03 | $250.82 2026-08-13 | +74.1% |
| 2022-02-09 | Josh Gottheimer | BUY | $1K–$15K | $143.20 | $250.82 2026-08-13 | +75.2% |
| 2022-01-28 | Josh Gottheimer | BUY | $1K–$15K | $137.92 | $250.82 2026-08-13 | +81.9% |
| 2022-01-21 | Thomas H Tuberville | SELL | $1K–$15K | $131.98 | $250.82 2026-08-13 | -90.0% exit |
| 2022-01-18 | Thomas R Carper | SELL | $1K–$15K | $136.78 | $250.82 2026-08-13 | +35.6% rt |
| 2021-12-13 | Adam B. Schiff | SELL | $15K–$50K | $126.51 | $250.82 2026-08-13 | -98.3% exit |
| 2021-11-26 | Bob Gibbs | BUY | $1K–$15K | $116.51 | $250.82 2026-08-13 | +115.3% |
| 2021-07-23 | Adam B. Schiff | SELL | $1K–$15K | $118.19 | $250.82 2026-08-13 | +2.0% rt |
| 2021-06-18 | Debbie Dingell | SELL | $50K–$100K | $113.12 | $250.82 2026-08-13 | +87.3% rt |
| 2021-06-16 | Marjorie Taylor Greene | BUY | $1K–$15K | $115.53 | $250.82 2026-08-13 | +117.1% |
| 2021-04-30 | Kathy Manning | SELL | $1K–$15K | $111.50 | $250.82 2026-08-13 | -125.0% exit |
| 2020-12-04 | Kenny Marchant | BUY | $1K–$15K | $107.28 | $250.82 2026-08-13 | +133.8% |
| 2020-11-20 | Thomas R Carper | BUY | $1K–$15K | $100.84 | $250.82 2026-08-13 | +148.7% |
| 2020-11-20 | Thomas R Carper | BUY | $1K–$15K | $100.84 | $250.82 2026-08-13 | +148.7% |
| 2020-11-20 | Joseph D. Morelle | SELL | $1K–$15K | $100.84 | $250.82 2026-08-13 | -148.7% exit |
| 2020-11-17 | Bob Gibbs | BUY | $15K–$50K | $99.21 | $250.82 2026-08-13 | +152.8% |
Return: buys marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (stock move after the sale, seller's perspective).
47 members of the U.S. House and Senate have disclosed AbbVie Inc. transactions under the STOCK Act — 68 purchases and 51 sales. The full member-by-member breakdown, with dates and dollar ranges, is in the table above.
No member of Congress has disclosed a ABBV purchase in the last 90 days. STOCK Act filings lag the trade by up to 45 days, so newer buys may still be pending disclosure.
Notional-weighted, lawmakers' disclosed ABBV buys are up 35.7% versus the latest close of $250.82. Each trade's own return — and realized round-trips on matched sells — is in the Return column.
Yes. Under the 2012 STOCK Act, members of Congress may buy and sell individual stocks but must publicly disclose each transaction within 45 days. Bargo surfaces those filings so you can see who traded ABBV and how it performed.